Dr Reddy's Laboratories and Purdue University sign an MOU for research

Dr Reddy's Laboratories has entered into a pact with Purdue university to strengthen research on various parameters, including drug delivery, manufacturing technology, scale-up of pharmaceutical operations, process engineering

Dr Reddy's Laboratories has set its focus on pharmaceuticals research, and the fact is reiterated with the company signing an MOU with the US-based Purdue University. The single fold objective of the partnership is to drive results in pharmaceutical processes and product development including, drug delivery, manufacturing technology, scale-up of pharmaceutical operations, process engineering, and research and development methodologies and technology.

According to a release sharing news on the development, The MoU will advance the "Purdue Moves" drug discovery initiative to translate basic research into life-changing treatments. Purdue University has proven expertise on the matter, and this development will only help them translate more discoveries through the delivery of a medicine or technology.

As reported by PTI

Suresh Garimella, Purdue executive vice-president for research and partnerships, and his counterpart Amit Biswas, executive vice-president and global head of integrated product development, signed the MoU last month.

Areas of planned collaborative research and education include targeted drug delivery, manufacturing technology, scale-up of pharmaceutical operations, process engineering, and research and development methodologies and technology.

"The collaboration will include student engagement and faculty exchanges and may include a site at Purdue Research Park," the statement further said.

Biswas said the long-term research partnership will help accelerate innovative drug development and manufacturing excellence.

"The long-term research partnership augurs well for DRL's philosophy of providing access to innovative, high-quality medicines to global patients at affordable cost," he added.